A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals for ...
Novartis could lose years of patent protection in the US for its blockbuster multiple sclerosis therapy Gilenya, after a federal appeals verdict went against the company. The litigation revolves ...
Abstract: Extremely large-scale multiple-input-multiple-output (XL-MIMO), which offers vast spatial degrees of freedom, has emerged as a potentially pivotal enabling technology for the sixth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback